- Clinical Interests
- Pituitary disease
- Pituitary tumors
- Prolactin Disorders
- Medical Education
- MD, New York University
- Residency, Bellevue Hospital Center
- Fellowship, Massachusetts General Hospital
- Board Certifications
- Diabetes & Metabolism
- Boston: Massachusetts General Hospital
- Patient Gateway
- Yes, learn more
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - other
- Harvard Pilgrim Health Plan - PBO
- Harvard Pilgrim Health Plan - SSN
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Patient Age Group
Anne Klibanski, MD is a clinician in the Neuroendocrine Clinical Center and Chief of the Neuroendocrine Unit at the Massachusetts General Hospital, and the Laurie Carrol Guthart Professor of Medicine at Harvard Medical School. She is a clinical researcher who studies pituitary tumors and the impact that pituitary and hypothalamic disorders have on body composition, including low bone mass.. Awards in recognition of her work have included The Endocrine Society Clinical Investigator Award and the British Trust Medal. She is the author of more than 350 peer-reviewed publications and has served on the Board of the NIH NIDDK Board of Counselors and on the Editorial Board of the Journal of Clinical Endocrinology and Metabolism. She is past-president of the Pituitary Society and serves on its Board. She has been involved in leadership positions of many educational programs sponsored by the Endocrine Society, the Pituitary Society and many patient advocacy groups to teach physicians and patients about pituitary tumors and neuroendocrine disorders.
- Research Summary
- Dr. Anne Klibanski is a clinical / translational investigator whose research has focused on two areas:
- The pathogenesis and development of new therapies for patients with pituitary tumors and
- An understanding of how neuroendocrine disorders can lead to low bone mass and the risk for osteoporosis. Specific research has focused on understanding acromegaly, prolactinomas, Cushing's disease and clinically non-functioning pituitary tumors.
- Klibanski A. Clinical practice. Prolactinomas. N Engl J Med. 2010; 362(13):1219-26
- Giustina A, et al. A consensus on the medical treatment of acromegaly. Nat Rev Endocrinol. 2014; 10(4):243-8.
On May 27, 12 fellows were honored at the Research Fellows Poster Day celebration, hosted by the Office for Research Career Development in the MGH Center for Faculty Development.
MGH Hotline 6.10.11 A world-renowned neurological researcher and clinician who has helped break down barriers for women in her field, Anne B. Young, MD, PhD, chief of the Department of Neurology, has a great deal of wisdom and insight to offer to colleagues.
MGH Hotline 10.08.10 In commemoration of Women in Medicine Month, the MGH last month hosted Eve J. Higginbotham, SM, MD, senior vice president and executive dean for Health Science at Howard University, who presented "Cracking the Glass Ceiling in Academic Medicine," Sept. 20 in the Thier Conference Room.
MGH Hotline 4.2.10
MGH Hotline 03.26.10 Dedicated to the career advancement of hospital faculty members, the MGH Center for Faculty Development (CFD) has been a vital resource for MGH faculty in support of their careers.
Zero Emerson Place
Boston MA, 02114-2217